Reproductive Endocrinologist
If you are a patient, please do not contact this physician by email without her prior expressed consent due to confidentiality concerns.
Contact Information
| Mailing Address: | 499 Illinois St. 6th Floor San Francisco, CA 94158 |
| Practice Phone: | 415-353-7475 |
Research/Clinical Interests
Assisted reproduction, fertility preservation, polycystic ovarian syndrome (PCOS), premature ovarian insufficiency.
Education/Training
| Year | Institution & Location | Degree | Field of Study |
|---|---|---|---|
| 2009 | The University of Texas Health Science Center, San Antonio | M.D. | Medicine |
| 2013 | Baylor College of Medicine, Houston | Residency | Obstetrics and Gynecology |
| 2016 | University of California, San Francisco, San Francisco | Fellowship | Reproductive Endocrinology and Infertility |
Achievements & Recognition
| Year | Major Honors |
|---|---|
| 2011 | Research grant awarded by the Department of Obstetrics and Gynecology, BCM |
| 2012 |
American Congress of Obstetricians and Gynecologists (ACOG) John Burch Endowment Fund Travel Award |
| 2012 |
Arthur M. Farris Resident Research Day, Oral Presentation - 1st place, Distinct Pathways Involved in Endometriosis-Associated Ovarian Cancer |
| 2012 |
Best Resident Award in the Division of Women’s Law and Health Policy, Department of Obstetrics and Gynecology, BCM |
| 2012 |
PGY3 Resident of the Year Award, Department of Obstetrics and Gynecology, BCM |
Selected Publications
Poirier C, Qin Y, Adams CP, Anaya Y, Singer JB, Hill AE, Lander ES, Nadeau JH, Bishop CE. A complex interaction of imprinted and maternal-effect genes modifies sex determination in Odd Sex (Ods) mice. Genetics. 2004; 168(3): 1557-1562.
Herndon CN, Anaya Y, Noel M, Cakmak H, Cedars MI. Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low resource socioculturally diverse urban community. Fert Steril. 2017;108(4):642-649.
Anaya Y, Mata DA, Letourneau J, Cakmak H, Cedars MI, Rosen MP. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization protocols. J Assist Reprod Genet. 2018;35(2):297-307.